R

C

ROSSO FERNÁNDEZ , Clara María

Last name: ROSSO FERNÁNDEZ

First name: Clara María

October 3, 2022 (v1)

Publication

Metadata-only

Factors associated with recruitment success in the phase 2a study of aztreonam–avibactam development programme: a descriptive qualitative analysis among sites in Spain

Jiménez Rodríguez, Rosa M. Martín-Gutiérrez, Guillermo Jiménez Jorge, Silvia

Objective Successful clinical trials are subject to recruitment. Recently, the REJUVENATE trial, a prospective phase 2a open-label, single-arm interventional clinical trial conducted within the Innovative Medicines Initiative-supported Combatting Bacterial Resistance in Europe-Carbapenem Resistance project, was published, with 85% of the...

Uploaded on: March 24, 2023
March 8, 2022 (v1)

Publication

Metadata-only

Temocillin versus meropenem for the targeted treatment of bacteraemia due to third-generation cephalosporin-resistant Enterobacterales (ASTARTÉ): protocol for a randomised, pragmatic trial

Marín Candón, Alicia Rosso Fernández, Clara María Bustos de Godoy, Natalia

Introduction: Alternatives to carbapenems are needed in the treatment of third-generation cephalosporin-resistant Enterobacterales (3GCR-E). Temocillin is a suitable candidate, but comparative randomised studies are lacking. The objective is to investigate if temocillin is non-inferior to carbapenems in the targeted treatment of bacteraemia due...

Uploaded on: March 25, 2023